Physician profile
Magali Selem
NPI 1437138690
$837.64
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $21.05 · 2022: $24.14 · 2023: $99.82 · 2024: $152 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $228.03 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Acadia Pharmaceuticals INC | $109.76 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $99.82 | 2023 | Rexulti |
| Pfizer INC. | $87.65 | 2019-2024 | |
| Cranial Technologies, INC | $80.62 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $66.29 | 2024-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Abbott Laboratories | $54.61 | 2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $38.93 | 2025 | Cobenfy |
| Sanofi Pasteur INC. | $38.10 | 2019 | |
| Theratechnologies INC. | $16.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magali Selem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.